Landrigan Philip J, Goldman Lynn R
Dean for Global Health, Ethel H. Wise Professor and Chairman, Department of Preventive Medicine, Professor of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York.
Am J Ind Med. 2014 Jan;57(1):1-3. doi: 10.1002/ajim.22268. Epub 2013 Oct 17.
On May 22, 2013, the late Senator Frank Lautenberg (D-NJ), Senator David Vitter (R-LA) and 19 of their colleagues introduced bipartisan chemical safety legislation in the US Senate, "The Chemical Safety Improvement Act of 2013." The bill's purpose is to protect human health and the environment against the hazards of toxic chemicals, by requiring the US Environmental Protection Agency (EPA) to examine the safety of all chemicals in consumer products. The bill is currently before the Senate Committee on Environment and Public Works, chaired by Senator Barbara Boxer (D-CA). This legislation is critically important for physicians and healthcare organizations because it creates significant new opportunities to prevent disease and cut healthcare costs.
2013年5月22日,已故参议员弗兰克·劳滕伯格(新泽西州民主党人)、参议员戴维·维特(路易斯安那州共和党人)及其19位同事在美国参议院提出了两党合作的化学品安全立法——“2013年化学品安全改进法案”。该法案的目的是通过要求美国环境保护局(EPA)审查消费品中所有化学品的安全性,来保护人类健康和环境免受有毒化学品危害。该法案目前已提交给由参议员芭芭拉·博克瑟(加利福尼亚州民主党人)担任主席的参议院环境与公共工程委员会。这项立法对医生和医疗保健组织至关重要,因为它为预防疾病和降低医疗成本创造了重要的新机会。